Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
Julianne Cynthia de RuiterJudi Nani Annet van DiessenEgbert Frederik SmitVincent van den NoortRonald Alphons Maria DamhuisKoen Johan Harteminknull nullPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
Unadjusted analyses revealed superior OS and PFS for MIL and similar LCSS, but this feasibility study was not sufficiently powered to demonstrate significant differences using propensity score methodology. Therefore, this study is currently being extended to include more than half of Dutch hospitals in order to enlarge the population to ≥1880 patients, not only to determine the best treatment for patients with stage I NSCLC overall, but also to assess the preferred treatment for patient groups with specific characteristics.